These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 8684526)

  • 1. Low-dose intradermal versus intramuscular hepatitis B vaccination in patients with end-stage renal failure. A preliminary study.
    Mettang T; Schenk U; Thomas S; Machleidt C; Kiefer T; Fischer FP; Kuhlmann U
    Nephron; 1996; 72(2):192-6. PubMed ID: 8684526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intradermal versus intramuscular hepatitis b re-vaccination in non-responsive chronic dialysis patients: a prospective randomized study with cost-effectiveness evaluation.
    Fabrizi F; Andrulli S; Bacchini G; Corti M; Locatelli F
    Nephrol Dial Transplant; 1997 Jun; 12(6):1204-11. PubMed ID: 9198052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review of the efficacy and safety of intradermal versus intramuscular hepatitis B vaccination in end-stage renal disease population unresponsive to primary vaccination series.
    Yousaf F; Gandham S; Galler M; Spinowitz B; Charytan C
    Ren Fail; 2015 Aug; 37(7):1080-8. PubMed ID: 26258528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose intradermal and subcutaneous versus intramuscular hepatitis B vaccination in primary non-responding hemodialysis patients.
    Sorkhi H; Dooki MR; Ebrahimnejad MS
    J Med Assoc Thai; 2006 Oct; 89(10):1648-53. PubMed ID: 17128839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evaluation of the effectiveness of multiple dose intradermal hepatitis B re-vaccination in hemodialyzed patients not responding to standard method of immunization.
    Radziszewski A; Gajda M; Pituch-Noworolska A; Drozdz M; Kraśniak A; Kaczmarczyk I; Hołyś S; Zurowski J; Sydor A; Sułowicz W
    Przegl Lek; 2007; 64(7-8):470-5. PubMed ID: 18409347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of intradermal hepatitis B vaccination compared to intramuscular vaccination in hemodialysis patients.
    Chanchairujira T; Chantaphakul N; Thanwandee T; Ong-Ajyooth L
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S33-40. PubMed ID: 17044452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody response to hepatitis B vaccine in end-stage renal disease patients.
    Chow KM; Law MC; Leung CB; Szeto CC; Li PK
    Nephron Clin Pract; 2006; 103(3):c89-93. PubMed ID: 16534237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete success of intradermal vaccination against hepatitis B in advanced chronic renal failure and hemodialysis patients.
    Vlassopoulos D; Arvanitis D; Lilis D; Hatjiyannakos D; Louizou K; Hadjiconstantinou V
    Ren Fail; 1997 May; 19(3):455-60. PubMed ID: 9154662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vaccination against hepatitis B virus. Value of intradermal administration in dialysed patients non responsive to intramuscular approach].
    Poux JM; Ranger-Rogez S; Lagarde C; Benevent D; Denis F; Leroux-Robert C
    Presse Med; 1995 May 6-13; 24(17):803-6. PubMed ID: 7630869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of intradermal route and dose of Hepatitis B vaccine administration in chronic dialysis patients: A pilot study.
    Jhorawat R; Shah P; Beniwal P; Agarwal D; Nijhawan S; Malhotra V
    Saudi J Kidney Dis Transpl; 2018; 29(2):376-380. PubMed ID: 29657206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized comparison of intradermal and intramuscular vaccination against hepatitis B virus in incident chronic hemodialysis patients.
    Charest AF; McDougall J; Goldstein MB
    Am J Kidney Dis; 2000 Nov; 36(5):976-82. PubMed ID: 11054354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete seroconversion by low-dose intradermal injection of recombinant hepatitis B vaccine in hemodialysis patients.
    Ono K; Kashiwagi S
    Nephron; 1991; 58(1):47-51. PubMed ID: 1830374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative immunogenicity of 2 recombinant hepatitis B vaccines (GeneVac-B and Engerix-B) in adult patients with chronic renal failure.
    Rajapurkar MM; Gang S; Dabhi M; Kulkarni PS
    J Nephrol; 2007; 20(5):596-601. PubMed ID: 17918146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of responsiveness to hepatitis B vaccination in patients on hemodialysis and peritoneal dialysis.
    Liu YL; Kao MT; Huang CC
    Vaccine; 2005 Jun; 23(30):3957-60. PubMed ID: 15917117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intradermal vs intramuscular vaccine against hepatitis B infection in dialysis patients: a meta-analysis of randomized trials.
    Fabrizi F; Dixit V; Messa P; Martin P
    J Viral Hepat; 2011 Oct; 18(10):730-7. PubMed ID: 20819147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low dose intradermal versus high dose intramuscular hepatitis B vaccination in patients on chronic hemodialysis.
    Roozbeh J; Moini M; Lankarani KB; Sagheb MM; Shahpoori S; Bastani B
    ASAIO J; 2005; 51(3):242-5. PubMed ID: 15968954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with a new recombinant hepatitis-B vaccine in previous non-responders with chronic renal insufficiency.
    Haubitz M; Ehlerding G; Beigel A; Heuer U; Hemmerling AE; Thoma HA
    Clin Nephrol; 1996 Mar; 45(3):180-2. PubMed ID: 8706359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of two schedules of hepatitis B vaccination in patients with mild, moderate and severe renal failure.
    Agarwal SK; Irshad M; Dash SC
    J Assoc Physicians India; 1999 Feb; 47(2):183-5. PubMed ID: 10999085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Randomized Controlled Trial of Seroconversion After 20 Mg versus 40 mg Intramuscular Hepatitis B Virus Vaccination in Patients with Chronic Kidney Disease Stage 3.
    Krairittichai U; Sethakarun S
    J Med Assoc Thai; 2017 Feb; 100 Suppl 1():S1-7. PubMed ID: 29926711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of anti-HBV vaccine efficacy given intradermally and intramuscularly in hemodialysis patients].
    Miłkowski A; Wyrwicz G; Kubit P; Smoleński O
    Przegl Lek; 2000; 57(11):628-34. PubMed ID: 11293210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.